Quantum Genomics Société Anonyme (ALQGC.PA)

EUR 0.07

(0.0%)

Revenue Summary of Quantum Genomics Société Anonyme

  • Quantum Genomics Société Anonyme's latest annual revenue in 2023 was 19.79 Thousand EUR , down -99.21% from previous year.
  • Quantum Genomics Société Anonyme's latest quarterly revenue in 2024 Q2 was - EUR , down 0.0% from previous quarter.
  • Quantum Genomics Société Anonyme reported a annual revenue of 2.51 Million EUR in annual revenue 2022, down -19.85% from previous year.
  • Quantum Genomics Société Anonyme reported a annual revenue of 3.13 Million EUR in annual revenue 2021, up 71.57% from previous year.
  • Quantum Genomics Société Anonyme reported a quarterly revenue of 12.00 EUR for 2023 Q4, down 0.0% from previous quarter.
  • Quantum Genomics Société Anonyme reported a quarterly revenue of 10.06 Thousand EUR for 2023 FY, down -99.6% from previous quarter.

Annual Revenue Chart of Quantum Genomics Société Anonyme (2023 - 2012)

Historical Annual Revenue of Quantum Genomics Société Anonyme (2023 - 2012)

Year Revenue Revenue Growth
2023 19.79 Thousand EUR -99.21%
2022 2.51 Million EUR -19.85%
2021 3.13 Million EUR 71.57%
2020 1.82 Million EUR 18.23%
2019 1.54 Million EUR 41869.61%
2018 3686.00 EUR 0.0%
2017 - EUR 0.0%
2016 - EUR -100.0%
2015 144.13 Thousand EUR -55.55%
2014 324.3 Thousand EUR 1763.82%
2013 17.4 Thousand EUR -9.38%
2012 19.2 Thousand EUR 0.0%

Peer Revenue Comparison of Quantum Genomics Société Anonyme

Name Revenue Revenue Difference
ABIONYX Pharma SA 4.64 Million EUR 99.573%
ABIVAX Société Anonyme 4.62 Million EUR 99.572%
Adocia SA 2.15 Million EUR 99.079%
Aelis Farma SA 9.05 Million EUR 99.781%
Biophytis S.A. - EUR -Infinity%
Advicenne S.A. 3.15 Million EUR 99.372%
genOway Société anonyme 20.04 Million EUR 99.901%
IntegraGen SA 12.53 Million EUR 99.842%
Medesis Pharma S.A. 300.03 Thousand EUR 93.402%
Neovacs S.A. 533.41 Thousand EUR 96.289%
NFL Biosciences SA - EUR -Infinity%
Plant Advanced Technologies SA 1.68 Million EUR 98.823%
Sensorion SA 4.74 Million EUR 99.583%
Theranexus Société Anonyme 296.33 Thousand EUR 93.32%
TME Pharma N.V. 17 Thousand EUR -16.447%
Valbiotis SA 4.73 Million EUR 99.582%
TheraVet SA 1.07 Million EUR 98.164%
Valerio Therapeutics Société anonyme 1.8 Million EUR 98.9%
argenx SE 1.13 Billion EUR 99.998%
BioSenic S.A. 543 Thousand EUR 96.354%
Celyad Oncology SA 102 Thousand EUR 80.592%
DBV Technologies S.A. - EUR -Infinity%
Galapagos NV 239.72 Million EUR 99.992%
Genfit S.A. 28.56 Million EUR 99.931%
GeNeuro SA - EUR -Infinity%
Hyloris Pharmaceuticals SA 2.08 Million EUR 99.051%
Innate Pharma S.A. 51.9 Million EUR 99.962%
Inventiva S.A. 17.47 Million EUR 99.887%
MaaT Pharma SA 2.22 Million EUR 99.111%
MedinCell S.A. 9.16 Million EUR 99.784%
Nanobiotix S.A. 30.05 Million EUR 99.934%
Onward Medical N.V. 532 Thousand EUR 96.279%
Oryzon Genomics S.A. 14.19 Million EUR 99.861%
OSE Immunotherapeutics SA 2.22 Million EUR 99.111%
Oxurion NV 263 Thousand EUR 92.473%
Pharming Group N.V. 245.31 Million EUR 99.992%
Poxel S.A. 1.98 Million EUR 99.001%
GenSight Biologics S.A. 1.26 Million EUR 98.438%
Transgene SA 1.18 Million EUR 98.328%
Financière de Tubize SA - EUR -Infinity%
UCB SA 5.25 Billion EUR 100.0%
Valneva SE 153.71 Million EUR 99.987%
Vivoryon Therapeutics N.V. -3.62 Million EUR 100.547%